← FDA Drug Approvals (Drugs@FDA)
ISRADIPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2006-01-05
Drug application
- FDA Application #
ANDA077317
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ISRADIPINE
- Generic name
- ISRADIPINE
- Active ingredients
- ISRADIPINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- WATSON LABS TEVA
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- First approval
- 2006-01-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown